News

New Research on Probiotics Shows Promise for Fighting Obesity

According to a new study published by George Mason University  researchers Dr. Robin Couch and Dr. Allyson Dailey, in collaboration with researchers at the  U.S. Department of Agriculture (USDA), showed probiotics may play a pivotal role in preventive  medicine.

High fat diets are a leading cause of obesity and can trigger the onset of metabolic syndrome.  The research team found that probiotic intervention has significant potential for addressing  obesity-related diseases.

The study examined the impact of a high fat diet in pigs. Organ tissue samples revealed that  probiotic supplementation countered many of the adverse consequences of a high fat diet  based on metabolite levels.

“Not only did we discover that the kidneys and brain are extremely sensitive to diets higher in  fat, but we also observed that probiotic supplementation reverted metabolite levels of pigs fed a  high fat diet to levels seen in pigs given a nutritionally balanced diet,” said Dr. Dailey.

Dr. Couch and Dr. Dailey worked with USDA researchers Dr. Gloria Solano-Aguilar, DVM, and  Dr. Joseph F. Urban on the study, which was published by Metabolites in February.

While only one probiotic strain was tested, Lacticaseibacillus paracasei (Chr. Hansen,  Denmark), the research team intends to explore the effects of other strains in the future.

“We’d like to see if certain probiotic strains are more advantageous for inducing changes in host  metabolic responses after consumption of high fat diet,” said Dr. Couch.

“Although more research is required before probiotic supplementation can be recommended as  part of one’s everyday routine, this study shows the effect it has on organ metabolite  composition,” said Dr. Couch. “The metabolome influence on the body is a blossoming field of study, and our results are further evidence that probiotics could contribute to normalize affected  metabolites, especially for those affected after consumption of a higher fat diet.”

Traditionally, probiotic research involves inspecting the gastrointestinal tract composition, such  as analyzing fecal microbiome composition or looking for inflammatory markers in blood  samples. By using organ tissue samples, researchers can directly measure the impact of  probiotics on metabolites in the body.

“This study shows that tissue derived metabolites can be modulated by dietary interventions.  However, additional research is needed to see if changes in these markers found in organs after

feeding probiotics could be followed in human samples of serum, urine or saliva,” said Dr.  Solano-Aguilar.

For more information, contact John Hollis at 571-396-1578 or jhollis2@gmu.edu

Recent News

04/24/2025

SSI Diagnostica Group Acquires Breath Test Maker Gulf Coast Scientific

Infectious disease diagnostics firm SSI Diagnostica Group said on Thursday that it has acquired Florida-based breath testing firm Gulf Coast Scientific for an undisclosed sum. Gulf Coast Scientific is a developer of urea breath tests for Helicobacter pylori infection, which is associated with conditions including chronic gastritis and gastric cancer. SSID Group said that the

04/23/2025

Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova’s board, and the successful completion of a new round of growth equity capital. These developments support Grenova’s strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories

04/22/2025

Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System, Ushering in a New Era of Modern Medicine Manufacturing in America

Phlow Corp., a leading pharmaceutical contract development and manufacturing organization (CDMO) in America, announced a significant expansion in its analytical capabilities, use of artificial intelligence (AI), workforce, and domestic infrastructure. Marking a period of exceptional growth and momentum, Phlow has more than doubled in size and now employs over 90+ highly skilled scientists and professionals